SCYNEXIS Inc (NASDAQ:SCYX)
| 2.19 Delayed Data As of 3:59pm ET |  -0.09 / -3.95%Today’s Change | 1.15 Today|||52-Week Range 3.87 | +40.38% Year-to-Date |
Latest SCYX News | Press Releases
| Verve Therapeutics (VERV) Soars 13.8%: Is Further Upside Left in the Stock? Sep 27 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains? Sep 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.28 |
| Today’s open | 2.17 |
| Day’s range | 2.15 - 2.23 |
| Volume | 5,064 |
| Average volume (3 months) | 395,889 |
| Market cap | $84.6M |
Data as of 3:59pm ET, 10/02/2023
Growth & Valuation
| Earnings growth (last year) | -18.33% |
| Earnings growth (this year) | +149.25% |
| Earnings growth (next 5 years) | +5.10% |
| Revenue growth (last year) | -61.32% |
| P/E ratio | 2.6 |
| Price/Sales | 13.06 |
| Price/Book | 23.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CMRXChimerix Inc | +0.00 | +0.48% |
| --Santhera Pharmaceuti... | 0.00 | 0.00% |
| CTMXCytomX Therapeutics ... | -0.06 | -4.65% |
| CLLSCellectis SA | -0.08 | -5.06% |
Data as of 3:59pm ET, 10/02/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $5.1M |
| Annual profit (last year) | -$62.8M |
| Net profit margin | -1,233.73% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jersey City, New Jersey |
Forecasts
